Draft Guidance for Industry on Notification to FDA of Issues that May Result in a Prescription Drug or Biological Product Shortage

1 organizations filed 1 public comment on Draft Guidance for Industry on Notification to FDA of Issues that May Result in a Prescription Drug or Biological Product Shortage, at the Food and Drug Administration. The comment window closed 5173d ago.

Commenters (1)

• National Community Pharmacists Associationtrade assoc.

  1 filing · confidence 97%